Recent

% | $
Quotes you view appear here for quick access.

Johnson & Johnson Message Board

  • mirror_world_man mirror_world_man Sep 21, 2013 12:24 AM Flag

    Invokana Gets Positive CHMP Opinion

    INVOKANA® (canagliflozin) Receives Positive Opinion Recommending Approval in the European Union for the Treatment of Adults with Type 2 Diabetes Mellitus1 September 20, 2013 09:14 AM Eastern Daylight Time
    BEERSE, Belgium--(BUSINESS WIRE)--Janssen-Cilag International NV (Janssen) announced today that the Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion recommending approval of INVOKANA® (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control.1 Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

 
JNJ
119.22+1.44(+1.22%)Sep 27 4:00 PMEDT